申请人:GRAFFINITY PHARMACEUTICALS AG
公开号:WO2005056013A1
公开(公告)日:2005-06-23
The invention relates to compounds of formula (I)wherein a dotted line indicates an optionally present double bond and wherein Z, R1 - R8, n, X1, X2, Y and T have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.